Bénéfices
| Q1 2024 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 4.130 | ||
| Révision: | $1.32B | $1.17B | — |
| Q4 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 2.730 | 2.800 | 0.0700 |
| Révision: | $1.27B | $833.57M | $9.00M |
| Q3 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 4.190 | 4.220 | 0.0300 |
| Révision: | $1.26B | $773.29M | $9.00M |
| Q2 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 4.290 | 4.760 | 0.4700 |
| Révision: | $1.29B | $731.73M | -$35.00M |
